Xilio Therapeutics Inc ( XLO ) shares are surging as the company announced an exclusive license agreement with Gilead Sciences Inc ( GILD ) to develop and commercialize Xilio’s Phase 1 tumor-activated IL-12 program, XTX301. Xilio Therapeutics ( XLO ) is using its proprietary tumor-activation platform to build a pipeline of novel, tumor-activated molecules, including antibodies, cytokines, bispecifics, and cell engagers, which are designed...

12:39 PM EDT, 03/28/2024 (MT Newswires) -- Moody's on Thursday upgraded the long-term issuer rating of Agnico Eagle Mines' ( AEM ) to Baa1 from Baa2. The outlook has been changed to stable from positive. The upgrade reflects Agnico's strengthened business profile following its acquisitions of Kirkland Lake Gold, and Yamana's interests in Canadian Malartic and Wasamac and management's commitment...

12:34 PM EDT, 03/28/2024 (MT Newswires) -- BuzzFeed ( BZFD ) and Independent Digital News & Media said Thursday they signed a multiyear license and strategic partnership deal in the UK and Ireland, combining publishing, data and ad-tech platforms to expand their commercial offerings and editorial scope. With the deal, The Independent combines BuzzFeed UK, Tasty UK, Seasoned and HuffPost...

12:44 PM EDT, 03/28/2024 (MT Newswires) -- (Corrects to indicate that Ford is considering the plan.) (Street Color news is derived from real time discussions with market professionals globally subscribed to the Street Color Premium Chat service on Bloomberg IB Chat and the ICE IM. This information is believed to be from reliable sources but may include rumor and speculation....